D-Wave Quantum (NYSE:QBTS) dips over 7% despite rolling out its Advantage2 system and warning the U.S. trails rivals in quantum annealing. D-Wave's latest Advantage2 machine is live in 40+ countries ...

Cathay Innovation said Tuesday it has closed its Fund III at $1 billion and will continue to back AI startups in digital ...

Contrary to a press release issued by RENB, the Delaware Court of Chancery recently rejected RENB’s request for an expedited, two-day trial in July. The Court reached this decision citing RENB’s delay ...

Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today issued the following statement regarding its dispute with Renovaro, Inc.

Dr. William K. Oh Appointed Founding Chair; Drs. Roy S. Herbst, Ranjit S. Bindra and Rajwanth Veluswamy join as Inaugural Members CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Archetype ...

In a landmark announcement that bridges Asia and Europe, Leo International Group has acquired a controlling stake in SPOABG ...

Recursion Pharmaceuticals RXRX and Schrodinger SDGR are pioneering the use of artificial intelligence (AI) in drug discovery ...

The Road Ahead From Singapore to Frankfurt, Leo International is building more than a business — it is building a bridge ...

Learn about Capex trends, data center growth, and how to invest in the infrastructure powering generative AI. Discover how hyperscaler capex is driving the future of cloud computing and AI.

GBAC “Quantum Healthcare 2025” board blueprint—$3.2 B QC drug-discovery market, 42 % CAGR, 50–70 % faster R&D cycles ...

Clinical trials, traditionally plagued by low success rates and high operational costs, are being reengineered through AI ...

Tempus AI TEM and Butterfly Network BFLY are two AI-driven healthcare infotech companies that have successfully reformed diagnostics through their complementary approaches. Tempus AI is leading the ...